Pharmaceutical Sector

.

To Escape Persistent Moves from Valeant Allergan Set to Sell Itself to Actavis

To Escape Persistent Moves from Valeant Allergan Set to Sell Itself to Actavis

To escape an unwanted takeover from Valeant Pharmaceuticals International, the Botox maker Allergan, in its recent defensive move, is planning to sell itself to another bidder Actavis.

New Tax Rules Can Discourage $55 billion AbbVie And Shire Pharma Merger

New Tax Rules Can Discourage $55 billion AbbVie And Shire Pharma Merger

The$55 billion merger deal of Chicago-based AbbVie with Shire, its U. K. rival could be the first victim of the new rules set by the Obama Administration to clean-up inversion deals.

Pharmaceutical Industry Jostle for Takeover Deals

Pharmaceutical Industry Jostle for Takeover Deals

The pharmaceutical industry is going through a lot of buzz as a number of companies are engaged in talks for acquisition and making deals. Some of the bigger players are busy trying to out-power their competitors.

Wockhardt Ltd soars after receiving QIDP status for two drugs

Wockhardt Ltd soars after receiving QIDP status for two drugs

Wockhardt Ltd BSE 3.72 % went up to 6.2 per cent in exchange on Monday, after the pharma major said that its new medication revelation program in hostile to infective exploration and has gotten a real help after two of its medications, WCK 771 and WCK 2349, got the Qualified Infectious Disease Product (QIDP) status from the US FDA.

Ackman and Valeant call for special meeting of Allergan shareholders

Ackman and Valeant call for special meeting of Allergan shareholders

William Ackman, who is an activist investor and Valeant Pharmaceuticals International have called for a special meeting with the shareholders of Allergan Inc over their takeover bid for the company.

Walgreen Looking Forward to Acquire 55% of Alliance Boots

Walgreen Looking Forward to Acquire 55% of Alliance Boots

Walgreen the major drugstore chain of late faced pressure from the shareholders to shift overseas so as to lessen its tax bill like many other drug companies have done recently. Walgreen was earlier looking forward to become a part of a possible agreement with Alliance Boots GmbH the European drugstore chain.

Novartis Expects major part of Revenue from New Products

Novartis Expects major part of Revenue from New Products

Novartis International AG, a Swiss multinational pharmaceutical company based in Basel, was ranked number one in sales among the world-wide industry in 2013.

On Thursday, Bombay Stock Exchange reported a 2% rise in quarterly sales of the company along with an expected future increase in the revenue of the company with the introduction of their new products.

Shire Gets Ready To Accept New Offer From AbbVie

Shire Gets Ready To Accept New Offer From AbbVie

Shire, the Dublin based drug manufacturer says that it is ready to urge a fresh £31bn takeover offer that came from AbbVie. It is entering into discussions with the firm after it received its fifth bid from the Chicago-based firm.

US approval for Qiagen

US approval for Qiagen

U. S. wellbeing controllers on Friday sanction Qiagen NV's gene-trying pack to recognize those colorectal malignancy patients destined to profit from Amgen Inc's pill, Vectibix, Qiagen said.

Still More to See in Pfizer's bid for AstraZeneca

Still More to See in Pfizer's bid for AstraZeneca

On Saturday, the story of takeover bid of the 63bn AstraZeneca by American pharmaceutical giant Pfizer took a new twist. It appeared that ministers have started discussions in Brussels regarding strengthening UK's capacity to pressurize the American firm to respect its commitment on issues related to jobs and research.

Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves
Syndicate content